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Objectives: Cerebral microbleeds (MBs) are known to be
indicative of bleeding-prone microangiopathy and may
predict incident intracerebral haemorrhage. However,
there is controversy concerning the causal relationship
between the presence of MBs and haemorrhagic
transformation (HTf) after ischaemic stroke.
Methods: Of the 1034 patients with acute ischaemic
stroke who were consecutively admitted to our hospital,
377 patients with stroke due to large-artery athero-
thrombosis or cardioembolism were selected for partici-
pation in this study. We examined the MBs using T2*-
weighted gradient-echo MRI performed within 24 hours
after admission, and the incidence of HTf was assessed
using follow-up brain MRI during the hospitalisation
period.
Results: Of the 377 patients with stroke, 234 were male
(62.1%) and the mean age was 66.2 ¡11.7 years. MBs
were initially found in 109 patients (28.9%), and newly
incident HTf was noted during the hospitalisation period in
74 patients (19.6%). The presence of MBs was not
increased in the patients with HTf (24.3% vs. 30.0% in the
patients without HTf; p = 0.331). In addition, the number
of MBs was not higher in the patients with HTf (0.7¡1.5
vs. 1.8¡8.1; p = 0.234). This lack of significance
between MBs and HTf persisted after stratification by
stroke mechanism.
Conclusions: This study suggests that underlying MBs
do not predict incident HTf after acute ischaemic stroke.
The clinical significance of MBs should be differentially
evaluated according to the type of disease (intracerebral
haemorrhage vs. HTf).
Microbleeds (MBs) visualised on brain T2*-
weighted gradient-echo (GRE) MRI are indicative
of chronic cerebral microangiopathy caused by
various conditions, including hypertension and
ageing.1–3 It has been suggested that the lesions
may predict subsequent haemorrhagic events such
as intracerebral haemorrhage4–6 and haemorrhagic
transformation (HTf) of ischaemic stroke.7 8 HTf
was determined to be one of the most important
risk factors leading to poor outcome in patients
with acute ischaemic stroke. However, the MBs do
not appear to predict an incident HTf after
thrombolysis in acute ischaemic stroke.9 10
Irrespective of thrombolysis, a prior study showed
that the presence of MBs may be associated with
HTf after acute ischaemic stroke,8 but the results
have not yet been confirmed. In this study, we
sought to investigate whether MBs that are present
at baseline are associated with subsequent HTf in
patients with acute ischaemic stroke by analysing
data on a larger, consecutive series of patients with




A total of 1034 acute ischaemic stroke patients
who had been admitted to Seoul National
University Hospital within 7 days after ictus were
consecutively enrolled in this study between
October 2002 and March 2006. Among the
patients, subjects with the following conditions
were excluded from this study according to the
classification of Trial of Org 10172 in Acute Stroke
Treatment (TOAST):11 patients with only transi-
ent ischaemic attack (n = 110), stroke due to small-
vessel disease (n = 289), stroke of undetermined
aetiology (n = 184), or stroke of other determined
aetiology (n = 15). Patients whose work-ups were
not complete due to various reasons were further
excluded. Therefore, our study population con-
sisted of a total of 377 patients with stroke due to
large-artery atherothombosis (n = 217) and cardi-
oembolism (n = 160).
Baseline demographic and clinical characteristics
were collected at admission and included age at
onset, gender, hypertension (previous use of anti-
hypertensive medication, systolic blood pressure
.140 mmHg or diastolic blood pressure
.90 mmHg at discharge), diabetes (previous use
of antidiabetic medication, fasting blood glucose
.7.0 mmol/L or postprandial blood glucose after
2 hours .11.1 mmol/L at discharge), hyperlipidae-
mia (previous use of lipid-lowering agents, total
cholesterol .6.0 mmol/L or low-density lipopro-
tein [LDL] cholesterol .4.14 mmol/L at admis-
sion), history of transient ischaemic attack or
stroke, previous use of antiplatelet or anticoagulant
medications, systolic and diastolic blood pressure
level at admission, glucose level, total cholesterol
level, prolonged prothrombin time or activated
partial thromboplastin time, initial National
Institutes of Health Stroke Scale (NIHSS) score,
and type of treatment during the acute stage
(thrombolysis, anticoagulant or antiplatelet medi-
cations).
All participants underwent brain MRI before the
initiation of thrombolytic or anti-thrombotic
therapy (within 24 hours after admission) and
follow-up brain GRE MRI. The MRI studies were
performed using a 1.5-Tesla superconducting mag-
net (GE Medical System, Milwaukee, WI, USA).
The standardised MRI protocol consisted of axial
T2-weighted spin echo (repetition time (TR)/echo
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time (TE), 2500–4500/80–112 ms; flip angle, 20u; slice thickness,
5 mm; gap width, 2 mm), axial GRE sequences (TR/TE, 200–
500/15 ms; flip angle, 20u; slice thickness, 5 mm; gap width,
2 mm) and diffusion-weighted imaging (repetition time (TR)/
echo time (TE), 4000/73 ms; flip angle, 90u; slice thickness,
5 mm; gap width, 2 mm). We examined the MBs present at
baseline by analysing the GRE image obtained at admission.
MBs were defined as focal homogeneous hypointense areas with
a diameter of 2–5 mm. Signal loss lesions secondary to globus
pallidus calcification or thrombus in the cerebral artery were
excluded. We determined the number and location of MBs in
each patient. The cerebral lesions (MBs and ischaemic stroke
lesions) were located in the cortical areas, deep grey matter,
brain stem and cerebellum. Old ischaemic or haemorrhagic
stroke lesions were also evaluated. Leukoaraiosis was classified
as being absent, or present as a punctate, early confluent or
confluent abnormality (as seen on T2-weighted MR images)
according to the method proposed by Fazekas et al.,12 and early
confluent or confluent lesions were compared in this study. HTf
was identified by follow-up brain GRE MRI and, according to
the prespecified criteria,13 the severity of HTf was graded into
four categories: haemorrhagic infarction (HI)-1 (small petechiae
along the margins of the infarct); HI-2 (more confluent
petechiae within the infarct but without space-occupying
effect); parenchymal hematoma (PH)-1 (blood clots not
exceeding 30% of the infarct area); and PH-2 (blood clots
exceeding 30% of the infarct area with significant space-
occupying effect).
Spearman’s rank correlation analysis was used to test inter-
observer reliabilities of MB numbers. Associations between
variables and incident HTf were examined by Pearson’s x2 test,
Fisher’s exact test and Student’s t test. The numbers of MBs
were compared according to the presence or the severity of HTf
using a nonparametric analysis (Mann–Whitney U test),
because the numbers of MBs were not normally distributed
(Kolmogorov–Smirnov test; p,0.05). All analyses were per-
formed using SPSS statistical software (Version 12.0.1). In all
tests, p,0.05 was noted as significant.
RESULTS
The inter-observer reliability of MB numbers between the
reading of observer 1 (S-HL) and observer 2 (B-SK) was high
(r = 0.87, p,0.001). Of the 377 patients included in this study,
234 patients were male (62.1%) and the mean age of the
subjects was 66.2¡11.7 years. There were 232 patients with
hypertension (61.5%), 118 with diabetes (31.3%) and 64 with
hyperlipidaemia (17.0%). Prior to admission, 100 patients
(26.5%) had a history of transient ischaemic attack or stroke,
40 patients (10.6%) had been prescribed antiplatelet agents and
27 patients (7.2%) had been prescribed anticoagulants. Incident
HTf was found in 74 patients (19.6%), and symptomatic HTf
was found in 13 patients (3.4%). Patients with incident HTf
were likely to receive thrombolytic treatment (p,0.001) and to
have a higher NIHSS score (p,0.001) (table 1). The interval
between the first imaging and the follow-up imaging ranged
from 1 to 17 days (mean, 6.0¡7.3 days; median, 8 days).
Baseline MBs revealed by GRE MRI were present in 109
patients (28.9%) and were most frequently located in the
cortical area (70 patients, 18.6%). The number of lesions ranged
from 0 to 122. As illustrated in table 2, among the patients with
incident HTf during the hospitalisation period, baseline MBs
were found in 18 patients (24.3%) and the association between
MBs and HTf was not significant (p = 0.331). Reclassification of
the subjects according to the location of the MBs (cortical, deep
grey matter, brain stem and cerebellum) did not affect the
results. When we limited the outcome to symptomatic HTf, an
association between the presence of MBs and symptomatic HTf
was not found (p = 0.637 by Pearson’s x2 test).
We also found that there was no association between the
number of MBs and the incident HTf (p = 0.234 by Mann–
Whitney U test) (table 2). According to the severity of HTf, no
significant differences were found (No HTf, 1.8¡8.1; HI-1,
1.1¡2.2; HI-2, 0.4¡1.0; PH-1, 0.4¡1.0; PH-2, 0.6¡1.2; p.0.05
in all comparisons using Mann–Whitney U test). Among the
radiological variables, patients with stroke lesions located in the
grey matter were more likely to have incident HTf during
hospitalisation (p = 0.001).
We performed two subgroup analyses based on stroke
mechanism and stroke location in order to identify any
significant relationships among the subgroups. In the initial
analysis based on stroke mechanism (large-artery atherothom-
bosis and cardioembolism), neither subgroup showed significant
association between MBs and incident HTf (data not
shown).There were also no significant results in the subgroup
analysis based on stroke location (cortical and deep grey matter)
(data not shown).
DISCUSSION
In this study, underlying MBs observed on the initial GRE MR
images were not associated with incident HTf occurring during
hospitalisation after acute ischaemic stroke. The presence,
number and location of MBs were not related to the incidence
of HTf, and there were no significant differences among the
groups classified according to HTf severity. In addition, no
significant relationships were found between HTf and any of
the subgroups. Stroke location (cortical-subcortical or deep grey
matter), use of thrombolytic agents and high initial NIHSS
score were associated with the subsequent haemorrhagic
transformations.
MBs indicate previous extravasation of blood, signifying
bleeding-prone cerebral microangiopathy.5–7 14 It has been
suggested that MBs may predict the incidence of intracerebral
haemorrhage.4 15 16 A previous study of 41 patients who under-
went intra-arterial thrombolysis demonstrated that the pre-
sence of baseline MBs could be a risk factor for symptomatic
HTf.7 On the other hand, a subsequent retrospective study of 44
patients who had received intravenous thrombolysis did not
replicate the positive association between MBs and HTf
reported in the previous study.10 Furthermore, a recent
prospective study, which was a part of the DEFUSE trial,
showed that MBs were detected in 11 out of 70 patients with
intravenous thrombolysis, and none of the 11 patients with
MBs at baseline had symptomatic HTf compared with 7 of the
59 patients who did not have baseline MBs (11.9%).9
Considering these results, MBs are not likely to be associated
with risk of HTf after thrombolysis. In this context, the
predictive value of MBs for subsequent HTf should be re-
evaluated in all types of HTf. A study on the effects of MBs on
early cerebral bleeding after acute ischaemic stroke reported that
MBs were found in 20 of 100 patients with acute ischaemic
stroke and in 10 of 26 patients with HTf (p,0.001).8 However,
the study had an important limitation: in 11 of the 20 patients
with MBs, GRE MRI was performed after the initiation of either
systemic thrombolysis or anti-thrombotic treatment (mainly
high-dose heparin), both of which may contribute to MBs or
HTf formation.8 17 In this study, all of the GRE MRIs were
performed before the initiation of thrombolytic or anti-
thrombotic therapy, and they did not confirm the positive
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association between the presence of baseline MBs and sub-
sequent incidence of HTf.
The underlying histopathologies of intracerebral haemorrhage
include rupture of penetrating arterioles damaged by hyaline
degeneration and microaneurysm formation caused by long-
standing hypertension or ageing.18–20 However, the pathophy-
siological mechanism of HTf formation after acute ischaemic
stroke is different from that of intracerebral haemorrhage.
Table 1 Demographic, clinical and laboratory findings in patients with stroke due to large-artery
atherothombosis or cardioembolism
HTf
p ValueAbsent (n = 303) Present (n = 74)
Demographic
Gender (male) 188 (62.0%) 46 (62.2%) 0.985
Age at admission (years) 66.1¡12.2 66.8¡9.8 0.643*
Clinical
Hypertension 186 (61.4%) 46 (62.2%) 0.902
Diabetes 92 (30.4%) 26 (35.1%) 0.427
Hyperlipidaemia 54 (17.8%) 10 (13.5%) 0.376
Smoking 100 (33.0%) 25 (33.8%) 0.898
History of transient ischaemic attack 21 (6.9%) 1 (1.4%) 0.093{
History of stroke 62 (20.5%) 16 (21.6%) 0.897
Previous use of antiplatelet agents 32 (10.6%) 8 (10.8%) 0.950
Previous use of anticoagulation 19 (6.3%) 8 (10.8%) 0.174
Initial NIHSS score 5.5¡5.9 10.3¡7.1 ,0.001*
Acute treatment
Thrombolysis 19(6.3%) 20(27.0%) ,0.001
Antiplatelet agents 115(38.0%) 31(41.9%) 0.533
Anticoagulation 179(59.1%) 29(39.2%) 0.002
Laboratory
Glucose (mmol/L) 6.44¡2.19 6.75¡2.10 0.294*
Total cholesterol (mmol/L) 4.72¡1.05 4.55¡0.99 0.208*
Systolic blood pressure (mmHg) 151.0¡25.5 149.9¡25.0 0.745*
Diastolic blood pressure (mmHg) 86.7¡15.1 85.8¡13.2 0.636*
Mean blood pressure (mmHg) 108.1¡17.1 107.2¡15.1 0.657*
Prolonged PT/aPTT (%) 63 (20.8%) 16 (21.6%) 0.875
Pearson’s x2 test, *Student t tests and {Fisher’s exact test were used.
aPTT, activated partial thromboplastin time; HTf, haemorrhagic transformation; NIHSS, National Institutes of Health Stroke Scale;
PT, prothrombin time.
Table 2 Analysis of radiological variables
HTf
p ValueAbsent (n = 303) Present (n = 74)
Presence of MBs
Whole brain 91 (30.0%) 18 (24.3%) 0.331
Cortical 59 (19.5%) 11 (14.9%) 0.361
Deep grey matter 55 (18.2%) 10 (13.5%) 0.344
Brain stem 35 (11.6%) 6 (8.1%) 0.394
Cerebellum 24 (7.9%) 3 (4.1%) 0.247
Number of MBs 1.8¡8.1 0.7¡1.5 0.234*
Location of stroke
Cortical 208 (68.6%) 59 (79.7%) 0.060
Deep grey matter 71 (23.4%) 32 (43.2%) 0.001
Brain stem 45 (14.9%) 6 (8.1%) 0.128
Cerebellum 52 (17.2%) 17 (23.0%) 0.246
Leukoaraiosis (early confluent or confluent) 79 (26.1%) 19 (25.7%) 0.944
Absent 115 (38.0%) 38 (51.4%)
Punctate 109 (36.0%) 17 (23.0%)
Early confluent 48 (15.8%) 15 (20.3%)
Confluent 31 (10.2%) 4 (5.4%)
Old stroke lesion
All stroke 96 (31.7%) 21 (28.4%) 0.582
Ischaemic stroke 90 (29.7%) 19 (25.7%) 0.493
Haemorrhagic stroke 10 (3.3%) 2 (2.7%) 0.793
Pearson’s x2 test and *Mann–Whitney U test were used.
HTf, haemorrhagic transformation; MBs, microbleeds.
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Ischaemic injury to the microvasculature in extensive brain
infarction is central to the risk of parenchymal haemorrhage
following thrombolytic treatment in stroke.21 An experimental
study demonstrated a correlation between the development of
HTf and the loss of basal lamina architecture.22 Because the
histopathological findings of MBs are similar to those of
symptomatic intracerebral haemorrhage, MBs may not be
associated with development of HTf in acute ischaemic stroke,
as found in this study.
There were some caveats of this study. First, our study was
conducted in a retrospective manner, and brain imaging was not
performed using a predetermined protocol. Despite this limita-
tion, we were able to determine the presence of incident HTf
because follow-up brain imaging was performed in most of the
patients (1001 out of 1034; 97%). Second, this study did not
evaluate the long-term effects of HTf, which is a major poor
prognostic factor in acute stroke. Third, this study did not
include patients with stroke due to small-vessel occlusion
because a rarity of incident HTf in this subtype of stroke might
have influenced the study results. Fourth, to focus on the
association between the MBs and HTf, we did not conduct a
multivariate analysis for identification of independent factors.
Finally, the development of HTf was more frequent in
cardioembolic stroke than in strokes due to other mechan-
isms.23 24 Our result showed a similar tendency (cardioembolism,
33%, 53/161; large-artery atherothombosis, 10%, 22/219);
however, there was no association between the presence of
MBs and incident HTf after stratification by stroke mechanism.
This study suggests that underlying MBs may not predict
incident HTf in acute ischaemic stroke. MBs reflect bleeding-
prone microangiopathy in the brain, but do not predict all forms
of subsequent bleeding. The predictive values of CMBs should
be differentially evaluated according to the type of disease
(intracerebral haemorrhage vs. HTf).
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